Latest Medivir News & Updates

See the latest news and media coverage for Medivir. We track all announcements, press releases, and industry mentions in real time, all in one place.

Medivir

Oncology drug discovery and development company

medivir.com

Headquarters: Huddinge, Sweden
Founded year: 1988
Company type: Public company
Number of employees: 10–48
Industry: Pharmaceuticals

Last updated August 27

Latest news about Medivir

In short: Medivir advanced fostrox and MIV-711 into Phase II studies and raised SEK 140 million

Company announcements

August 27 Medivir

Medivir publishes its interim report for January through June 2027

The document provides details on the company's performance and status during the first half of the calendar year.

August 20 Medivir

Medivir reports Q2 2026 financial results and clinical progress

The company secured SEK 140 million via directed share issue. Clinical milestones include FLEX-HCC enrollment initiation and MIV-711 expansion into Perthes disease.

August 6 Medivir

Medivir publishes interim report for January-September 2026

The webcast will present the company's financial results and operational highlights for the first nine months of 2026.

July 31 Medivir

Medivir announces share and vote totals after directed share issue

The oversubscribed issue includes new investors and finances MIV-711 for Legg-Calvé-Perthes disease.

Media coverage

August 19 Finanznachrichten

Medivir AB: Interim Report January - June 2026

"With three Phase II studies funded, FLEX-HCC recruitment on track, and MIV-711 expanded into a second rare bone indication, Medivir is in its strongest position...

June 17 Omni

Medivir tops up the cash for drug projects

After the stock market closed, the pharmaceutical company Medivir announced plans for a directed new share issue of around 130 million kronor. This is stated in a press release.

May 5 Finanznachrichten

Medivir AB: Interim Report January - March 2026

"Following a transformative first quarter and strong external interest in our two key programs, we are well positioned to create long-term value for shareholders." January...

February 18 Finanznachrichten

Medivir AB: Year-end Report January - December 2025

"With a strengthened ownership base, a strong financial position, and two groundbreaking projects in clinical development, we now have expanded opportunities to create long-term value...

Never miss news about Medivir

Track Medivir and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Medivir competitors & trending companies

Browse news for competitors to Medivir and other trending companies.